Skip to main content
. 2023 Jun 28;15(13):2925. doi: 10.3390/nu15132925

Figure 1.

Figure 1

Evolution of body mass and systolic blood pressure. (A,B) Evolution of BM through 18 weeks in grams (g). (A) Body mass in pretreatment period. From the 4th week, the HFD animals had a significant increase in BM when compared to the CD. (B) Body mass in post-treatment period. The CD and CD + CO groups showed constant and significantly lower body mass than the HFD and HFD + CO groups. The HFD + CO group showed a non-significant reduction in body mass compared to the HFD group. (C) Systolic blood pressure measured in pre- and post-treatment period in millimeters of mercury (mmHg). The HFD group showed a significant increase in SBP compared to the CD group in the pre-treatment period. In the post-treatment period, the HFD and HFD + CO groups showed a significant increase in relation to the CD and CD + CO groups. The HFD + CO group showed a significant reduction in levels in the last week of treatment when compared to the HFD group. (a) represents p < 0.05 compared to the CD group, (b) represents p < 0.05 compared to the CD + CO group and (c) p < 0.05 compared to the HFD + CO group. n = 6 for all experimental groups.